Satellite Symposia

Hear directly from industry in these popular one-hour presentations. Please check back as more symposia are added. Note: CE Credit is not offered for these Satellite Symposia. 

Friday, January 27

12:15–1:15 pm PT

Appropriate Use Criteria for Estrogen Receptor (ER) – Targeted PET Imaging with 16a-18f-Fluoro-17b-Fluoroestradiol (18F-FES)
Sponsored by GE Healthcare

Speaker: Gary Ulaner, MD, PhD, FACNM
James & Pamela Muzzy Endowed Chair of Molecular Imaging & Therapy
Hoag Family Cancer Institute, Newport Beach, CA.  
Professor of Radiology and Translational Genomics, University of Southern California

Learn why 16a-18F-fluoro-17b-flurorestradiol (18F-FES) is important. How does 18F FES-Fluoroestradiol assess whole body Estrogen Receptor (ER)-status and Appropriate Use Criteria of 18F FES-Fluoroestradiol PET.  

Saturday, January 28

12:30–1:30 pm PT

PSMA PET in Prostate Cancer: Case Studies from 1-Year Clinical Use Post FDA-Approval
Sponsored by Lantheus

Speaker: Hong Song, MD, PhD 

New imaging agents have been approved by the FDA for PET imaging of PSMA (prostate specific membrane protein) in prostate cancer patients for over one year. Clinically,  PSMA PET plays a more important role in many aspects of prostate cancer patient care including local disease detection, primary staging, biochemical recurrence, treatment response and patient screening for 177Lu-PSMA. I will review a series of cases in prostate cancer from our institution.